600 related articles for article (PubMed ID: 29312125)
1. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurol; 2017; 8():701. PubMed ID: 29312125
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Retinopathy: Seeing Disease in the Eyes.
Mirzaei N; Shi H; Oviatt M; Doustar J; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurosci; 2020; 14():921. PubMed ID: 33041751
[TBL] [Abstract][Full Text] [Related]
3. Retinal Vasculopathy in Alzheimer's Disease.
Shi H; Koronyo Y; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Mirzaei N; Koronyo-Hamaoui M
Front Neurosci; 2021; 15():731614. PubMed ID: 34630020
[TBL] [Abstract][Full Text] [Related]
4. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
5. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
[TBL] [Abstract][Full Text] [Related]
6. The role of optical coherence tomography in Alzheimer's disease.
Cunha LP; Almeida AL; Costa-Cunha LV; Costa CF; Monteiro ML
Int J Retina Vitreous; 2016; 2():24. PubMed ID: 27847642
[TBL] [Abstract][Full Text] [Related]
7. [Optical Coherence Tomography in Disorders of the Central Nervous System].
Papadopoulou A; Oertel FC; Zimmermann H; Zeitz O; Brandt AU; Paul F
Klin Monbl Augenheilkd; 2018 Nov; 235(11):1242-1258. PubMed ID: 30458564
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography.
Wojtkowski M; Srinivasan V; Fujimoto JG; Ko T; Schuman JS; Kowalczyk A; Duker JS
Ophthalmology; 2005 Oct; 112(10):1734-46. PubMed ID: 16140383
[TBL] [Abstract][Full Text] [Related]
9. [Retinal OCT biomarkers and neurodegenerative diseases of the central nervous system beyond Alzheimer's disease].
Hopf S; Tüscher O; Schuster AK
Ophthalmologie; 2024 Feb; 121(2):93-104. PubMed ID: 38263475
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease pathophysiology in the Retina.
Gaire BP; Koronyo Y; Fuchs DT; Shi H; Rentsendorj A; Danziger R; Vit JP; Mirzaei N; Doustar J; Sheyn J; Hampel H; Vergallo A; Davis MR; Jallow O; Baldacci F; Verdooner SR; Barron E; Mirzaei M; Gupta VK; Graham SL; Tayebi M; Carare RO; Sadun AA; Miller CA; Dumitrascu OM; Lahiri S; Gao L; Black KL; Koronyo-Hamaoui M
Prog Retin Eye Res; 2024 Jul; 101():101273. PubMed ID: 38759947
[TBL] [Abstract][Full Text] [Related]
11. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye.
Lee S; Jiang K; McIlmoyle B; To E; Xu QA; Hirsch-Reinshagen V; Mackenzie IR; Hsiung GR; Eadie BD; Sarunic MV; Beg MF; Cui JZ; Matsubara JA
Front Neurosci; 2020; 14():758. PubMed ID: 32848548
[TBL] [Abstract][Full Text] [Related]
12. Association of Retinal Changes With Alzheimer Disease Neuroimaging Biomarkers in Cognitively Normal Individuals.
Byun MS; Park SW; Lee JH; Yi D; Jeon SY; Choi HJ; Joung H; Ghim UH; Park UC; Kim YK; Shin SA; Yu HG; Lee DY;
JAMA Ophthalmol; 2021 May; 139(5):548-556. PubMed ID: 33764406
[TBL] [Abstract][Full Text] [Related]
13. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.
Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042
[TBL] [Abstract][Full Text] [Related]
14. Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.
Chrysou A; Jansonius NM; van Laar T
Parkinsonism Relat Disord; 2019 Jul; 64():40-49. PubMed ID: 31054866
[TBL] [Abstract][Full Text] [Related]
15. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.
Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY
J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254
[TBL] [Abstract][Full Text] [Related]
16. Nonvascular retinal imaging markers of preclinical Alzheimer's disease.
Snyder PJ; Johnson LN; Lim YY; Santos CY; Alber J; Maruff P; Fernández B
Alzheimers Dement (Amst); 2016; 4():169-178. PubMed ID: 27830174
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review.
Tsokolas G; Tsaousis KT; Diakonis VF; Matsou A; Tyradellis S
Eye Brain; 2020; 12():73-87. PubMed ID: 32765149
[TBL] [Abstract][Full Text] [Related]
18. Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography.
Gharbiya M; Trebbastoni A; Parisi F; Manganiello S; Cruciani F; D'Antonio F; De Vico U; Imbriano L; Campanelli A; De Lena C
J Alzheimers Dis; 2014; 40(4):907-17. PubMed ID: 24577467
[TBL] [Abstract][Full Text] [Related]
19. The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Normando EM; Davis BM; De Groef L; Nizari S; Turner LA; Ravindran N; Pahlitzsch M; Brenton J; Malaguarnera G; Guo L; Somavarapu S; Cordeiro MF
Acta Neuropathol Commun; 2016 Aug; 4(1):86. PubMed ID: 27535749
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.
La Morgia C; Di Vito L; Carelli V; Carbonelli M
Front Neurol; 2017; 8():710. PubMed ID: 29312131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
